TY - JOUR
T1 - Familial communication and cascade testing among relatives of BRCA population screening participants
AU - Lieberman, Sari
AU - Lahad, Amnon
AU - Tomer, Ariela
AU - Koka, Sivan
AU - BenUziyahu, Malka
AU - Raz, Aviad
AU - Levy-Lahad, Ephrat
N1 - Publisher Copyright:
© 2018, American College of Medical Genetics and Genomics.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Purpose: Population BRCA1/BRCA2 screening identifies carriers irrespective of family history, yet this information is actionable for relatives. We examined familial communication rates and cascade testing in the screening setting and assessed sociodemographic and psychosocial predictors. Methods: Participants in a BRCA1/BRCA2 screening study of healthy Ashkenazi Jews self-administered a family communication questionnaire. Intent to communicate was determined before genetic status was known, along with result communication (carriers and noncarriers) 6 months and 2 years after enrollment. Carriers underwent in-depth interviews and provided cascade testing information. Results: In total, 88% (524/595) of questionnaire responders and 97% (30/32) of carriers informed at least one relative. In multivariate analysis, family history (P = 0.005) and greater Satisfaction With Health Decision scores (P < 0.001) predicted communication of results. Among carriers’ adult first- and second-degree relatives, 71 (48%) had cascade testing, more commonly performed in first- (58%) than in second-degree relatives (26%, P = 0.0002), and in females (56%) vs. males (36%, P = 0.02). At least 11% remained uninformed. Conclusion: Familial communication rates and characteristics in a screening setting parallel those reported by Cancer Genetics clinics. Universal screening circumvents dependence on familial disclosure. However, our finding that satisfaction—a potentially modifiable factor—predicts communication, raises the hypothesis that improving the testing experience could facilitate familial communication.
AB - Purpose: Population BRCA1/BRCA2 screening identifies carriers irrespective of family history, yet this information is actionable for relatives. We examined familial communication rates and cascade testing in the screening setting and assessed sociodemographic and psychosocial predictors. Methods: Participants in a BRCA1/BRCA2 screening study of healthy Ashkenazi Jews self-administered a family communication questionnaire. Intent to communicate was determined before genetic status was known, along with result communication (carriers and noncarriers) 6 months and 2 years after enrollment. Carriers underwent in-depth interviews and provided cascade testing information. Results: In total, 88% (524/595) of questionnaire responders and 97% (30/32) of carriers informed at least one relative. In multivariate analysis, family history (P = 0.005) and greater Satisfaction With Health Decision scores (P < 0.001) predicted communication of results. Among carriers’ adult first- and second-degree relatives, 71 (48%) had cascade testing, more commonly performed in first- (58%) than in second-degree relatives (26%, P = 0.0002), and in females (56%) vs. males (36%, P = 0.02). At least 11% remained uninformed. Conclusion: Familial communication rates and characteristics in a screening setting parallel those reported by Cancer Genetics clinics. Universal screening circumvents dependence on familial disclosure. However, our finding that satisfaction—a potentially modifiable factor—predicts communication, raises the hypothesis that improving the testing experience could facilitate familial communication.
KW - Ashkenazi Jews
KW - BRCA1/2
KW - cascade testing; familial communication
KW - population screening
UR - http://www.scopus.com/inward/record.url?scp=85056573970&partnerID=8YFLogxK
U2 - 10.1038/gim.2018.26
DO - 10.1038/gim.2018.26
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29595811
AN - SCOPUS:85056573970
SN - 1098-3600
VL - 20
SP - 1446
EP - 1454
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 11
ER -